Avoiding room temperature storage and delayed cryopreservation provide better postthaw potency in hematopoietic progenitor cell grafts

Transfusion

Volumn 53, Issue 8, 2013, Pages 1834-1842

  Fry, Laura Jayne ^a   Giner, Sergio Querol ^a   Gomez, Susana G ^a   Green, Melanie ^a   Anderson, Sally ^a   Horder, Jackie ^a   McArdle, Stephanie ^a   Rees, Robert ^a   Madrigal, Jose Alejandro ^a  

^a NOTTINGHAM TRENT UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL COUNT; CELL POPULATION; CELL VIABILITY; COLONY FORMING UNIT; CONTROLLED STUDY; CRYOPRESERVATION; FLOW CYTOMETRY; FREEZING; HEMATOPOIETIC STEM CELL; ROOM TEMPERATURE; STORAGE; STORAGE TEMPERATURE;

CELL COUNT; CELL SURVIVAL; CORD BLOOD STEM CELL TRANSPLANTATION; CRYOPRESERVATION; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; TEMPERATURE; TIME FACTORS; TISSUE PRESERVATION;

EID: 84882451814     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12006     Document Type: Article

References (32)

1. Appelbaum FR, Sullivan KM, Buckner CD,. Treatment of malignant lymphoma in 100 patients with chemotherapy, total body irradiation, and marrow transplant. J Clin Oncol 1987; 5: 1340-1347.
2. Eaves CJ,. Peripheral blood stem cells reach new heights. Blood 1959; 82: 1957-1959.
3. Jansen J, Nolan PL, Reeves MI, Morgan JA, Akard LP, Thompson JM, Dugan MJ, Hanks SG,. Transportation of peripheral blood progenitor cell products: effect of ambient temperature. Cytotherapy 2010; 12: 919-923.
4. Jansen J, Hanks SG, Akard LP, Morgan JA, Nolan PL, Dugan MJ, Reeves MI, Thompson JM,. Slow platelet recovery after peripheral blood progenitor cell transplantation from unrelated donors. Bone Marrow Transplant 2009; 43: 499-505.
5. Lazarus HM, Kan F, Tarima S, Champin RE, Confer DL, Frey N, Gee AP, Wagner JE, Horowitz MM, Eapen M,. Rapid transport and infusion of hematopoietic cells is associated with improved outcome after myeloablative therapy and unrelated donor transplant. Biol Blood Marrow Transplant 2009; 15: 589-596.
6. Tron de Bouchony E, Pelletier D, Alcalay D, Bruneau J, Predeau M, Brizard A, Magnin M,. Hematopoietic progenitor content of fetal cord blood collected using citrate-phosphate-dextrose: influence of holding temperature and delays. J Hematother 1993; 2: 271-273.
7. Shlebak AA, Marley SB, Roberts IA, Davidson RJ, Goldman JM, Gordon MY,. Optimal timing for processing and cryopreservation of umbilical cord. Bone Marrow Transplant 1999; 23: 131-136.
8. Rogers I, Sutherland A, Holt D, Macpate F, Lains A, Hollowell S, Cruickshank B, Casper RF,. Human UC-blood banking: impact of blood volume, cell separation and cryopreservation on leukocyte and CD34+ cell recovery. Cytotherapy 2001; 3: 269-276.
9. Hubel A, Carlquist D, Clay M, McCullough J,. Short-term liquid storage of umbilical cord blood. Transfusion 2003; 43: 626-632.
10. Hubel A, Carlquist D, Clay M, McCullough J,. Cryopreservation of cord blood after liquid storage. Cytotherapy 2003; 5: 370-376.
11. Hubel A, Carlquist D, Clay M, McCullough J,. Liquid storage, shipment, and cryopreservation of cord blood. Transfusion 2004; 44: 518-525.
12. Tsagias N, Kouzi-Koliakos K, Karagiannis DH, Alamdari V, Koliakos G,. Time and temperature before processing influence the recovery of umbilical cord blood hematopoietic progenitors. Transfusion 2007; 47: 1550-1552.
13. Rubinstein P, Rosenfield RE, Adamson JW, May WS,. Stored placental blood for unrelated bone marrow reconstitution. Blood 1993; 81: 1679-1690.
14. Campos L, Roubi N, Guyotat D,. Definition of optimal conditions for collection and cryopreservation of umbilical cord hematopoietic cells. Cryobiology 1995; 32: 511-515.
15. Kurtz J, Shalini S, Greco N, Moroff G,. Assessment of cord blood hematopoietic cell parameters before and after cryopreservation. Transfusion 2007; 47: 1578-1586.
16. Broxmeyer HE, Gluckman E, Auerbach A, Douglas GW, Friedman H, Cooper S, Hangoc G, Kurtzberg J, Bard J, Boyse EA,. Human umbilical cord blood: a clinically useful source of transplantable hematopoietic stem/progenitor cells. Int J Cell Cloning 1990; 8: 76-91.
17. Broxmeyer HE, Kurtzberg J, Gluckman E, Auerbach AD, Douglas G, Cooper S, Falkenburg JH, Bard J, Boyse EA,. Umbilical cord blood hematopoietic stem and repopulating cells in human clinical transplantation. Blood Cells 1991; 17: 313-329.
18. Moroff G, Seetharaman S, Kurtz JW, Greco NJ, Mullen MD, Lane TA, Law P,. Retention of cellular properties of PBPCs following liquid storage and cryopreservation. Transfusion 2004; 44: 245-2.
19. Sugrue MW, Hutcheson CE, Fisk DD, Roberts CG, Mageed A, Wingard JR, Moreb JS,. The effect of overnight storage of leukapheresis stem cell products on cell viability, recovery, and cost. J Hematother 1998; 7: 431-436.
20. Jestice HK, Scott MA, Ager S, Tolliday BH, Marcus RE,. Liquid storage of peripheral blood progenitor cells for transplantation. Bone Marrow Transplant 1994; 14: 991-994.
21. Ruiz-Arguelles GJ, Ruiz-Arguelles A, Perez-Romano B, Marin-Lopez A, Larregina-Diez A, Apreza-Molina MG,. Filgrastim-mobilized peripheral-blood stem cells can be stored at 4 degrees and used in autografts to rescue high-dose chemotherapy. Am J Hematol 1995; 48: 100-103.
22. Petzer AL, Gunsilius E, Zech N, Clausen J, Hoflehner E, Nussbaumer W, Gastl G,. Evaluation of optimal survival of primitive progenitor cells (LTC-IC) from PBPC apheresis products after overnight storage. Bone Marrow Transplant 2000; 25: 197-200.
23. Beaujean F, Pico J, Norol F, Divine M, Le Forestier C, Duedari N,. Characteristics of peripheral blood progenitor cells frozen after 24 hours of liquid storage. J Hematother 1996; 5: 681-686.
24. Lasky LC, McCullough J, Zanjani ED,. Liquid storage of unseparated human bone marrow evaluation of hematopoietic progenitors by clonal assay. Transfusion 1986; 26: 331-334.
25. Mangalik A, Robinson WA, Drebing C, Hartmann D, Joshi JH,. Liquid storage of bone marrow. Exp Hematol 1979; 7: 76-94.
26. Kohsaki M, Yanes B, Ungerleider JS, Murphy MJ Jr,. Non-frozen preservation of committed hematopoietic stem cells from normal human bone marrow. Stem Cells 1981; 1: 111-123.
27. Antonenas V, Garvin F, Webb M, Sartor M, Bradstock KF, Gottlieb D,. Fresh PBSC harvests, but not BM, show temperature related loss of CD34 viability during storage and transport. Cytotherapy 2006; 8: 158-165.
28. Haas R, Witt B, Mohle R, Goldschmidt H, Hohaus S, Freuhauf S, Wannenmacher M, Hunstein W,. Sustained long-term hematopoiesis after myeloablative therapy with peripheral blood progenitor cell support. Blood 1995; 85: 3754-3761.
29. Rowley SD, Zuehlsdorf M, Braine HG, Colvin OM, Davis J, Jones RJ, Saral R, Sensenbrenner LL, Yeager A, Santos GW,. CFU-GM content of bone marrow graft correlates with time to hematologic reconstitution following autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide-purged bone marrow. Blood 1987; 70: 271-275.
30. Yoo KH, Lee SH, Kim HJ, Sung KW, Jung HL, Cho EJ, Park HK, Kim HA, Koo HH,. The impact of post-thaw colony-forming units-granulocyte/macrophage on engraftment following unrelated cord blood transplantation in pediatric recipients. Bone Marrow Transplant 2007; 39: 515-521.
31. Keeney M, Chin-Yee I, Weir K, Popma J, Nayar R, Sutherland RS,. Single platform flow cytometric absolute CD34+ cell counts based on the ISHAGE guidelines. Cytometry 1998; 34: 61-70.
32. International NetCord Foundation and Foundation for the Accreditation of Cellular Therapy. NetCord-FACT international standards for cord blood collection, banking, and release for administration. 4th ed. 2010. [cited 2012 Nov 16]. Available from: URL: www.factwebsite.org.